loadpatents
name:-0.0073800086975098
name:-0.0032470226287842
name:-0.0015277862548828
EMADI; Ashkan Patent Filings

EMADI; Ashkan

Patent Applications and Registrations

Patent applications and USPTO patent grants for EMADI; Ashkan.The latest application filed is for "asparaginase-induced glutamine depletion combined with bcl-2 inhibition for treatment of hematologic and solid cancers".

Company Profile
1.3.8
  • EMADI; Ashkan - Clarksville MD US
  • Emadi; Ashkan - Bethesda MD US
  • Emadi; Ashkan - Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Asparaginase-induced Glutamine Depletion Combined With Bcl-2 Inhibition For Treatment Of Hematologic And Solid Cancers
App 20220054606 - EMADI; Ashkan ;   et al.
2022-02-24
Aziridinyl And Amino Dimeric Naphthoquinone Compounds And Use For Acute Myeloid Leukemia
App 20200283417 - Emadi; Ashkan ;   et al.
2020-09-10
Compositions and methods for the treatment of cancers
Grant 9,381,215 - Emadi , et al. July 5, 2
2016-07-05
Compositions and Methods for the Treatment of Cancers
App 20150231176 - Emadi; Ashkan ;   et al.
2015-08-20
Metabolic Inhibitor Against Tumors Having An Idh Mutation
App 20130109643 - Riggins; Gregory Joseph ;   et al.
2013-05-02
Anti-viral multi-quinone compounds and regiospecific synthesis thereof
Grant 6,828,347 - Stagliano , et al. December 7, 2
2004-12-07
Anti-viral multi-quinone compounds and regiospecific synthesis thereof
App 20040087663 - Stagliano, Kenneth William ;   et al.
2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed